158 related articles for article (PubMed ID: 23643633)
1. Sulodexide improves renal function through reduction of vascular endothelial growth factor in type 2 diabetic rats.
Cha JJ; Kang YS; Hyun YY; Han SY; Jee YH; Han KH; Han JY; Cha DR
Life Sci; 2013 Jun; 92(23):1118-24. PubMed ID: 23643633
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH
J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
[TBL] [Abstract][Full Text] [Related]
3. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
[TBL] [Abstract][Full Text] [Related]
4. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
Kang YS; Ko GJ; Lee MH; Song HK; Han SY; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2009 Jan; 24(1):73-84. PubMed ID: 18682491
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of thiazolidinediones on diabetic nephropathy in OLETF rats.
Lee MY; Lee EY; Lee BJ; Won CS; Koh JH; Shin JY; Shin YG; Cho BP; Chung CH
Yonsei Med J; 2007 Apr; 48(2):301-7. PubMed ID: 17461531
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
[TBL] [Abstract][Full Text] [Related]
7. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
[TBL] [Abstract][Full Text] [Related]
8. [Renal protective effects of sulodexide in diabetic rats and its anti-oxidative mechanism].
Shu J; Zeng LY; Lin KY; Mu PW; Zhang GC; Chen YM; Wang MM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):778-80. PubMed ID: 19403420
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
Lee EY; Kim GT; Hyun M; Kim S; Seok S; Choi R; Lee MY; Chung CH
Nephrol Dial Transplant; 2012 Nov; 27(11):4069-79. PubMed ID: 22892126
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.
Ogawa M; Hirawa N; Tsuchida T; Eguchi N; Kawabata Y; Numabe A; Negoro H; Hakamada-Taguchi R; Seiki K; Umemura S; Urade Y; Uehara Y
Nephrol Dial Transplant; 2006 Apr; 21(4):924-34. PubMed ID: 16384826
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
[TBL] [Abstract][Full Text] [Related]
12. Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats.
Kang KS; Yamabe N; Kim HY; Park JH; Yokozawa T
Biol Pharm Bull; 2010; 33(6):1077-81. PubMed ID: 20522983
[TBL] [Abstract][Full Text] [Related]
13. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
[TBL] [Abstract][Full Text] [Related]
14. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
[TBL] [Abstract][Full Text] [Related]
15. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
Yamabe N; Yokozawa T
J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372
[TBL] [Abstract][Full Text] [Related]
16. Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria.
Yongwatana K; Supasyndh O; Satirapoj B
J Diabetes Res; 2020; 2020():2984680. PubMed ID: 32851094
[TBL] [Abstract][Full Text] [Related]
17. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
[TBL] [Abstract][Full Text] [Related]
18. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats.
Fujita A; Sasaki H; Doi A; Okamoto K; Matsuno S; Furuta H; Nishi M; Nakao T; Tsuno T; Taniguchi H; Nanjo K
Diabetes Res Clin Pract; 2008 Jan; 79(1):11-7. PubMed ID: 17897750
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats.
Li C; Yang CW; Park CW; Ahn HJ; Kim WY; Yoon KH; Suh SH; Lim SW; Cha JH; Kim YS; Kim J; Chang YS; Bang BK
Kidney Int; 2003 Feb; 63(2):454-63. PubMed ID: 12631111
[TBL] [Abstract][Full Text] [Related]
20. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
